Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharina E Meijboom

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 6, 2022
Approaches to Gene Modulation Therapy for ALSKatharina E Meijboom, Robert H Brown
Genes|June 13, 2017
Splice-Switching Therapy for Spinal Muscular AtrophyKatharina E Meijboom, Matthew J A Wood, Graham McClorey
JCI Insight|July 8, 2021
Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophyKatharina E Meijboom, Viola Volpato, Jimena Monzón-Sandoval, et al.
Gene Therapy|September 26, 2023
Artificial microRNA suppresses C9ORF72 variants and decreases toxic dipeptide repeat proteins in vivoGabriela Toro Cabrera, Katharina E Meijboom, Abbas Abdallah, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2016
Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophySuzan M Hammond, Gareth Hazell, Fazel Shabanpoor, et al.
Human Molecular Genetics|July 9, 2018
Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy miceLisa M Walter, Christiane E Koch, Corinne A Betts, et al.
Skeletal Muscle|July 28, 2022
Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy miceKatharina E Meijboom, Emma R Sutton, Eve McCallion, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 5, 2015
Reducing Ventral Tegmental Dopamine D2 Receptor Expression Selectively Boosts Incentive MotivationJohannes W de Jong, Theresia J M Roelofs, Frédérique M U Mol, et al.
Ebiomedicine|May 9, 2018
Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy MiceLisa M Walter, Marc-Olivier Deguise, Katharina E Meijboom, et al.
Life Science Alliance|August 14, 2021
Dystrophin involvement in peripheral circadian SRF signallingCorinne A Betts, Aarti Jagannath, Tirsa LE van Westering, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 6, 2022
Approaches to Gene Modulation Therapy for ALSKatharina E Meijboom, Robert H Brown
Genes|June 13, 2017
Splice-Switching Therapy for Spinal Muscular AtrophyKatharina E Meijboom, Matthew J A Wood, Graham McClorey
JCI Insight|July 8, 2021
Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophyKatharina E Meijboom, Viola Volpato, Jimena Monzón-Sandoval, et al.
Gene Therapy|September 26, 2023
Artificial microRNA suppresses C9ORF72 variants and decreases toxic dipeptide repeat proteins in vivoGabriela Toro Cabrera, Katharina E Meijboom, Abbas Abdallah, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2016
Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophySuzan M Hammond, Gareth Hazell, Fazel Shabanpoor, et al.
Human Molecular Genetics|July 9, 2018
Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy miceLisa M Walter, Christiane E Koch, Corinne A Betts, et al.
Skeletal Muscle|July 28, 2022
Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy miceKatharina E Meijboom, Emma R Sutton, Eve McCallion, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 5, 2015
Reducing Ventral Tegmental Dopamine D2 Receptor Expression Selectively Boosts Incentive MotivationJohannes W de Jong, Theresia J M Roelofs, Frédérique M U Mol, et al.
Ebiomedicine|May 9, 2018
Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy MiceLisa M Walter, Marc-Olivier Deguise, Katharina E Meijboom, et al.
Life Science Alliance|August 14, 2021
Dystrophin involvement in peripheral circadian SRF signallingCorinne A Betts, Aarti Jagannath, Tirsa LE van Westering, et al.
Pageof 2